Multi-omic and spatial analysis reveals tumour-derived paracrine signals drive suppressive macrophage polarisation via activation of the cAMP-CREB axis in glioblastoma

This study utilizes multi-omic and spatial analyses to reveal that glioblastoma-derived paracrine signals drive immunosuppressive macrophage polarization through the activation of the cAMP-CREB signaling axis.

The Gist

The Big Picture: A City Under Siege

Imagine the human brain as a bustling city. Glioblastoma (GBM) is a very aggressive, criminal gang that has taken over a neighborhood in this city. Their goal is to expand their territory and destroy the city's defenses.

The city's natural defense force is the immune system, specifically a type of soldier called a Macrophage. Think of macrophages as the "good guys" or the "police" who patrol the streets, looking for criminals to arrest and destroy.

The Problem: The Police Get Brainwashed

The paper discovers something terrifying about how this criminal gang (the tumor) survives.

1. The Arrival: New police officers (monocytes) arrive from the outside world (the bloodstream) to help. When they are still in the "police car" (the blood vessel), they are alert, angry, and ready to fight the bad guys. They are in "M1 mode" (the aggressive, good-guy mode).
2. The Trap: As soon as these officers step out of their cars and walk onto the criminal's turf (the tumor tissue), the gang leaders (tumor cells) start whispering in their ears.
3. The Switch: The gang uses secret signals to trick the police. The officers stop fighting and start helping the criminals. They switch to "M2 mode" (the lazy, helpful, bad-guy mode). They stop arresting criminals and start building walls to protect them.

The Secret Weapon: The "cAMP-CREB" Radio

The researchers wanted to know: How exactly does the tumor gang trick the police?

They found the answer lies in a specific communication channel inside the police officer's brain.

• The Signal: The tumor cells release tiny, invisible messengers (proteins smaller than 10kDa—think of them as tiny, invisible drones).
• The Receiver: When these drones hit the police officer, they turn on a specific radio station inside the cell called cAMP.
• The Commander: This radio station activates a commander inside the cell called CREB.

The Analogy: Imagine the tumor cells are broadcasting a "Stop Fighting" signal on a specific frequency. The CREB commander is the only one with a radio tuned to that frequency. Once CREB hears the signal, he gives the order to the rest of the cell: "Stand down! Stop attacking! Start helping the criminals!"

The Evidence: How They Proved It

The scientists did three main things to prove this theory:

1. Looking at the Crime Scene (Spatial Analysis): They looked at brain tumor tissue under a microscope.

   • Inside the blood vessels (the police cars): The officers were still angry and ready to fight (no CREB signal).
   • Inside the tumor (the streets): The officers were calm, sleepy, and helping the tumor (CREB was glowing bright, showing the signal was active).
   • Conclusion: The switch happens the moment they leave the safety of the blood vessel and enter the tumor.

2. The Lab Experiment (The "Off" Switch): They took police cells in a dish and exposed them to tumor signals. The cells turned "bad."

   • Then, they used a special chemical inhibitor (a jammer) to block the CREB radio.
   • Result: Even with the tumor signals present, the cells refused to turn bad. They stayed angry and ready to fight. This proves that CREB is the master switch.

3. Reading the Orders (Genetic Analysis): They looked at the "to-do lists" (genes) inside the cells.

   • When CREB was active, the cells started producing a list of "helpful" chemicals (like IL-10 and CCL2) that calm down the immune system and feed the tumor.
   • When they jammed the CREB radio, these "helpful" chemicals stopped being produced.

Why This Matters: A New Way to Win the War

For a long time, doctors have tried to attack the tumor gang directly with drugs, but the gang is very good at hiding and fighting back.

This paper suggests a new strategy: Don't just attack the gang; retrain the police.

If we can find a drug that blocks that specific "cAMP-CREB" radio frequency, we can stop the tumor from brainwashing the immune system.

• The police would stay angry and aggressive.
• They would stop building walls for the tumor.
• They would start destroying the cancer cells again.

The Takeaway

The tumor doesn't just fight the immune system; it hacks it. It uses a tiny, invisible signal to flip a switch (CREB) inside the immune cells, turning defenders into traitors. By understanding this switch, scientists hope to build a "jammer" that keeps the immune system awake and fighting, giving patients a much better chance of survival against this deadly brain cancer.

Technical Summary

1. Problem Statement

Glioblastoma (GBM) is an aggressive brain cancer with a poor prognosis, largely due to a highly immunosuppressive tumor microenvironment (TME). A key driver of this suppression is the infiltration of Tumor-Associated Macrophages (TAMs), specifically Bone Marrow-Derived Macrophages (BMDMs), which can constitute up to 50% of the tumor mass. While it is known that BMDMs shift from an inflammatory (M1-like) state to an immunosuppressive (M2-like) state within the tumor, the specific molecular mechanisms governing this transition, the upstream signaling pathways involved, and the exact tumor-secreted factors responsible remain poorly understood. This study aims to define the spatiotemporal dynamics of TAM polarization and identify the signaling axis driving the immunosuppressive phenotype in GBM.

2. Methodology

The study employed a comprehensive multi-omics approach integrating spatial proteomics, transcriptomics, and proteomics:

• Clinical Samples & Spatial Analysis:
  • Analyzed 59 human brain tumor tissues (Grade 2–4 astrocytomas and GBM) and non-tumor controls.
  • Used Multiplex Immunohistochemistry (mIHC) (Opal 7-color) to co-stain for macrophage markers (CD68, CD163, CD206, HLA-DR, TMEM119) and signaling markers (pCREB, pAKT, pERK).
  • Performed spatial infiltration analysis to map macrophage phenotypes relative to blood vessels (perivascular niches) and the tumor parenchyma (neoplastic cell-rich regions).
• In Vitro Models:
  • Used human monocytic THP-1 cells and primary monocyte-derived macrophages (MDM) from healthy donors.
  • Stimulated macrophages with Conditioned Medium (CM) from various GBM cell lines (including patient-derived MU41 and standard lines like U87MG, LN229).
  • Applied pharmacological inhibitors to dissect signaling pathways: CREB inhibitor (666-15), cAMP/PKA inhibitor (H89), PI3K inhibitor (BKM-120), and MAPK inhibitor (U0126).
• Omics Profiling:
  • RNA Sequencing (RNA-seq): Performed on MDMs stimulated with GBM-CM (± CREB inhibitor) to identify differentially expressed genes (DEGs) and CREB target transcripts.
  • Proteomics: Used Olink Target 96 Inflammation panel and LEGENDplex Cytometric Bead Array to quantify secreted cytokines and chemokines in cell supernatants.
  • Fractionation: Size-exclusion filtration (<10kDa, 10–30kDa, >30kDa) and Proteinase K treatment to characterize the molecular nature of the active factors in GBM-CM.

3. Key Contributions

• Spatiotemporal Polarization Mapping: Demonstrated that circulating BMDMs enter GBM tumors as inflammatory (HLA-DR+ CD163-) cells but rapidly polarize to an immunosuppressive (HLA-DR- CD163+) state upon exiting the vasculature and entering the tumor parenchyma.
• Identification of the cAMP-CREB Axis: Established that the cAMP-PKA-CREB signaling axis is the primary driver of this immunosuppressive polarization, explicitly ruling out PI3K/AKT and MAPK/ERK pathways in this specific context.
• Characterization of Tumor-Derived Factors: Identified that GBM cells secrete low molecular weight (<30kDa) protein factors (distinct from exosomes) that trigger CREB activation.
• Definition of CREB Targetome: Systematically identified 13 specific CREB-regulated genes in TAMs that encode immunosuppressive cytokines, chemokines, and extracellular matrix (ECM) proteins.

4. Key Results

A. Spatial Dynamics of TAM Polarization

• Vascular vs. Parenchymal: Within tumor blood vessels and perivascular niches, TAMs are predominantly HLA-DR+ (inflammatory) and pCREB-negative.
• Parenchymal Shift: Once macrophages migrate into the tumor parenchyma (>25µm from vessels), they shift to an HLA-DR- CD163+ (immunosuppressive) phenotype.
• CREB Activation: Phosphorylated CREB (pCREB) is highly enriched in parenchymal TAMs (approx. 70% co-express CD163) but absent in vascular TAMs. This activation correlates with tumor grade, being highest in GBM.

B. Mechanism of Activation

• GBM Secreted Factors: Exposure of macrophages to GBM-conditioned medium (specifically from high-invasive lines like MU41 and LN229) induced rapid pCREB phosphorylation and CREB transactivation.
• Pathway Specificity:
  • Inhibition of cAMP/PKA (using H89) completely blocked CREB phosphorylation.
  • Inhibition of PI3K or MAPK had no effect on CREB phosphorylation.
  • Inhibition of CREB (using 666-15) blocked the expression of M2 markers (e.g., CD206) and downstream cytokines.
• Molecular Nature of Factors: The active factors in GBM-CM were found to be proteins smaller than 30kDa (specifically <10kDa for robust pCREB induction) and were sensitive to Proteinase K, confirming they are low-molecular-weight polypeptides, not exosomes.

C. CREB Target Genes and Secreted Profile

• Transcriptomics: RNA-seq revealed that GBM stimulation upregulated 530 genes. CREB inhibition (666-15) downregulated 17 specific transcripts, identifying them as direct CREB targets.
• Key Targets: The 13 confirmed CREB-regulated genes include:
  • Immunosuppressive Cytokines: IL10, CCL2 (MCP-1), CCL8, CXCL10.
  • ECM/Modifying Proteins: VCAN (Versican), HAPLN3.
  • Anti-apoptotic/Survival: SERPINA9.
• Proteomics: Olink and CBA analysis confirmed that these mRNA changes translate to protein secretion. CREB inhibition significantly reduced the secretion of immunosuppressive chemokines (CCL23, MCP-2, MCP-3, IL-10, CXCL10, CXCL6, CCL19, CCL11, MCP-4).

5. Significance

• Therapeutic Targeting: The study identifies the cAMP-CREB axis as a critical vulnerability in GBM. Pharmacological inhibition of CREB not only reprograms TAMs from an immunosuppressive (M2) to a less suppressive state but also targets the neoplastic cells themselves (based on previous work by the authors).
• Mechanistic Insight: It resolves the "black box" of how tumor cells reprogram infiltrating monocytes, showing that the transition is driven by specific, low-molecular-weight paracrine signals acting through cAMP signaling.
• Biomarker Potential: The spatial distribution of pCREB+ TAMs serves as a potential biomarker for tumor aggressiveness and the degree of immunosuppression within the TME.
• Future Directions: These findings suggest that combining CREB inhibitors with immunotherapies could overcome the "cold" tumor phenotype of GBM by reactivating anti-tumor immunity via macrophage reprogramming.